Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -5.913% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] Fc1ccccc1N1CCN(C2CCCN(Cc3ccccc3C(F)(F)F)C2)CC1
[b] Cc1oc2ccc(O)c(CN3CCOCC3)c2c1C(C)O
[c] CCC1(C)Cc2ccccc2-c2nc(NCCCO)n(C)c(=O)c21
Answer: a. Fc1ccccc1N1CCN(C2CCCN(Cc3ccccc3C(F)(F)F)C2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Fc1ccccc1N1CCN(C2CCCN(Cc3ccccc3C(F)(F)F)C2)CC1
Fc1ccccc1N1CCN(C2CCCN(Cc3ccccc3C(F)(F)F)C2)CC1
1-(2-fluorophenyl)-4-[1-[[2-(trifluoromethyl)phenyl]methyl]piperidin-3-yl]piperazine